Technical Analysis for PRPO - Precipio, Inc.

Grade Last Price % Change Price Change
F 1.85 -5.61% -0.11
PRPO closed down 5.61 percent on Friday, April 16, 2021, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical PRPO trend table...

Date Alert Name Type % Chg
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion -5.61%
Oversold Stochastic Weakness -5.61%
Pocket Pivot Bullish Swing Setup -9.76%
Lower Bollinger Band Walk Weakness -9.76%
Wide Bands Range Expansion -9.76%
Oversold Stochastic Weakness -9.76%
Older End-of-Day Signals for PRPO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Lower Bollinger Band Support about 8 hours ago
2x Volume Pace about 10 hours ago
1.5x Volume Pace about 10 hours ago
Down 5% about 10 hours ago
Down 3% about 10 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Precipio, Inc. Description

Precipio, Inc., formerly Transgenomic, Inc., is a biotechnology company. The Company is engaged in advancing personalized medicine for the detection and treatment of cancer, and inherited diseases through its molecular technologies and clinical and research services. The Company operates through its Laboratory Services segment. The Company is engaged in the provision of its Multiplexed ICE COLD-PCR (MX-ICP) product to the clinical market, enabling the use of blood and other bodily fluids for diagnosis, monitoring and treatment of cancer. MX-ICP amplifies the ability to detect genetic mutations by approximately 100 to 400 fold. MX-ICP is validated internally on sequencing platforms, including Sanger, Next Gen Sequencing and Digital polymerase chain reaction (PCR). Its laboratory in Omaha, Nebraska is focused on providing genetic analytical services related to oncology and pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted.


Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Cancer Biology Diseases Natural Sciences Treatment Of Cancer Molecular Biology Multiplex Genomics Research Services Omaha Molecular Diagnostics Laboratory Services Analytical Services Laboratory Techniques Polymerase Chain Reaction Personalized Medicine Digital Polymerase Chain Reaction Pharmacogenomics

Is PRPO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 8.0
52 Week Low 0.55
Average Volume 626,937
200-Day Moving Average 2.35
50-Day Moving Average 2.59
20-Day Moving Average 2.22
10-Day Moving Average 2.08
Average True Range 0.19
ADX 17.92
+DI 13.52
-DI 29.09
Chandelier Exit (Long, 3 ATRs ) 2.16
Chandelier Exit (Short, 3 ATRs ) 2.35
Upper Bollinger Band 2.60
Lower Bollinger Band 1.84
Percent B (%b) 0.01
BandWidth 34.23
MACD Line -0.16
MACD Signal Line -0.13
MACD Histogram -0.025
Fundamentals Value
Market Cap 31.87 Million
Num Shares 17.2 Million
EPS -5.81
Price-to-Earnings (P/E) Ratio -0.32
Price-to-Sales 4.94
Price-to-Book 2.75
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.10
Resistance 3 (R3) 2.10 2.02 2.06
Resistance 2 (R2) 2.02 1.95 2.02 2.04
Resistance 1 (R1) 1.93 1.92 1.89 1.93 2.03
Pivot Point 1.85 1.85 1.83 1.85 1.85
Support 1 (S1) 1.77 1.79 1.73 1.77 1.67
Support 2 (S2) 1.69 1.75 1.69 1.66
Support 3 (S3) 1.60 1.69 1.64
Support 4 (S4) 1.60